• Product NameAmbroxol
• Brief DescriptionInhibitors
• Purification99.00%
• Biological ActivityAmbroxol is indicated as "secretolytic therapy in bronchopulmonary diseases associated with abnormal mucus secretion and impaired mucus transport. It promotes mucus clearance, facilitates expectoration and eases productive cough, allowing patients to breathe freely and deeply.
• Target NameP450 inhibitor
• CAS No. 18683-91-5
• Calculated MW 378.1
• Formulation C13H18Br2N2O
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Respiratory system
  SMILES:NC1=C(Br)C=C(Br)C=C1CNC1CCC(O)CC1
  Pathways:Metabolism
  Receptor:CYP3A
  Boling pt:
  Melting pt:233-234 C
  Solubility:Soluble in DMSO
  Appearance:White Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Preissner S, et al. Nucleic Acids Res. 2010, 38(Database issue):D237-43.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting